Sims Andrew John Hugh MacIntyre Insider Trades

Insider Trading History

Track insider trading activity for Sims Andrew John Hugh MacIntyre. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $40.6k 9,941 shares
Last Trade
Jul 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.4k 2,985 shares
$4.16
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $116k 28,522 shares
Last Trade
Jul 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.4k 2,985 shares
$4.16
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $196k 48,138 shares
Last Trade
Oct 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$25.6k 38,323 shares
$0.67
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $1.72M 421,555 shares
Last Trade
Oct 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$25.6k 38,323 shares
$0.67
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $5.63M 1,379,636 shares
Last Trade
Aug 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$786k 1,379,636 shares
$0.57
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $245k 60,020 shares
Last Trade
Feb 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.8k 60,020 shares
$1.18
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $188k 46,074 shares
Last Trade
Sep 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$58.1k 46,074 shares
$1.26
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $40k 9,815 shares
Last Trade
Sep 10, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.2k 4,098 shares
$1.27
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $23.3k 5,717 shares
Last Trade
May 08, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.1k 4,902 shares
$2.27
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $40k 9,804 shares
Last Trade
May 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.3k 9,804 shares
$2.27
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $77.2k 18,933 shares
Last Trade
Feb 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$38.4k 18,933 shares
$2.03
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $426k 104,404 shares
Last Trade
Feb 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.16M 104,404 shares
$87.75
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $49.9k 12,230 shares
Last Trade
Apr 26, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$459k 3,000 shares
$152.96
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $37.7k 9,230 shares
Last Trade
Mar 01, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$495k 2,000 shares
$247.50
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $29.5k 7,230 shares
Last Trade
Nov 02, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$423k 1,000 shares
$423.00
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $25.4k 6,230 shares
Last Trade
Oct 26, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$761k 2,000 shares
$380.25
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $17.3k 4,230 shares
Last Trade
Jul 28, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$990k 2,244 shares
$441.00
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $8.1k 1,986 shares
Last Trade
Jul 27, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$871k 1,986 shares
$438.75
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $409k 100,197 shares
Last Trade
May 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51M 100,197 shares
$508.50
$4.08
Plus Therapeutics
Plus Therapeutics PSTV
Chief Financial Officer
Holding Value $272k 66,625 shares
Last Trade
Feb 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.5M 66,625 shares
$787.50
$4.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up